Product Information
Name:BIIB-024
Brand:Biosynth
Description:BIIB-024 is a monoclonal antibody that targets mutant melanoma cells. It binds to the tumor and prevents it from growing, as well as preventing the cancer cells from spreading. BIIB-024 has shown effectiveness in clinical studies by reducing tumor size and skin reactions in patients with melanoma. The effective dose of BIIB-024 is 10 milligrams per kilogram of body weight. BIIB-024 also inhibits protein synthesis in tumor cells, which may be due to its ability to bind to cytosolic proteins.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:506.29 g/mol
Formula:C17H12Cl2F3N7O2S
Purity:Min. 95%
Technical inquiry about: BIIB-024
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.